The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Ranked by engagement

Top topics — all time page 40

Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

1,535 topics · page 40 of 40

TopicParticipantsRepliesViewsActivity
[2026 update] Evidence quality in the secretagogue literature: an honest assessment
Posting this under the heading it deserves: Evidence quality in the secretagogue literature: an honest assessment Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with STEP 1 ( N…
SDSSHKLFES+14 18 3.1k 6mo
What to include when your question involves a laboratory result
Asking directly, because I could not find a straight answer: What to include when your question involves a laboratory result Question in the title. Context below, and I have tried to include the things people…
ZOJCELCRES+8 12 14k 2d
Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? — that is the question, and I have not found it answered plainly anywhere I have looked. Session topic: SCALE ( N Engl J Med , 2015). Please read it…
JSRASMNAKF+5 9 13k 25d
Alcohol: what is documented and what is folklore — the long version
Alcohol: what is documented and what is folklore — the long version — setting out what I have, and where I think it stops being reliable. Reporting something rather than asking about it, in case the pattern…
ADNISSZOPI+9 13 7.3k 6mo
Follow-up: What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in support…
NKSADM 2 25k 11mo
Long-time reader, first-time poster
On the subject in the title: Long-time reader, first-time poster Working notes rather than a conclusion. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something adjacent…
FPICPJHVN+15 19 2.5k 8mo
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold?
Asking directly, because I could not find a straight answer: Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? General question, not a request for advice about my own…
EFBPWM 2 22k 11mo
Second pass at: What to keep a record of at the point of payment
Second pass at: What to keep a record of at the point of payment — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
RSCVDSIAOO+14 18 1.9k 4mo
A comparison of home results against a laboratory result on the same vial — does this still hold?
A comparison of home results against a laboratory result on the same vial — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Working through the…
BKZSCPFYLP+2 6 15k 11h
Coming back to: Reconstitution volumes that produce round numbers, tabulated
On the subject in the title: Reconstitution volumes that produce round numbers, tabulated Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly…
CDMNC 2 24k 6mo
Second pass at: Counter-ion content and its effect on measured mass
Second pass at: Counter-ion content and its effect on measured mass Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like…
SORSLAFFOV 4 16k 4mo
Trust level 3 requirements: a clarification
Trust level 3 requirements: a clarification — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps…
ECSVSSNCJW+10 14 7k 9mo
Over-dilution: when your dose falls below one readable graduation
On the subject in the title: Over-dilution: when your dose falls below one readable graduation Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am…
KKAAAWMMKS+15 19 248 15mo
[2026 update] Comparing tirzepatide and semaglutide is harder than the tables suggest
Comparing tirzepatide and semaglutide is harder than the tables suggest Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021) with SURMOUNT-1…
BAIDO 2 23k 21mo
Follow-up: Attributing a new peak: degradation product or excipient?
Attributing a new peak: degradation product or excipient? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
KIABCSGV+15 19 671 17mo
Cold packs, phase-change material, and what survives ten days — does this still hold?
Asking directly, because I could not find a straight answer: Cold packs, phase-change material, and what survives ten days — does this still hold? A logistics question, since the answers here are usually…
PRKMO 2 22k 22mo
What a confidence interval means, from scratch — the long version
The question in the title: What a confidence interval means, from scratch — the long version I will give what I have already checked below so nobody repeats it. I have seen SURMOUNT-2 ( Lancet , 2023) cited…
OVTSAWCEBW+16 20 2.3k 8mo
Subcutaneous absorption kinetics and site differences
Posting this under the heading it deserves: Subcutaneous absorption kinetics and site differences Everything below is what sits behind that. I would like to understand what this number means before I repeat…
NRVRMRNSS+15 19 3.9k 12mo
About the Reconstitution category
Diluent choice, volumes, resulting concentrations, worked examples, and the errors we see most often. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
SLKNBNNLC+1 5 15k 16h
Coming back to: Cross-border purchase rules within the EU
Cross-border purchase rules within the EU Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…
JEDBNRPFFE+12 16 2.8k 11mo
Introducing myself and asking whether my planned first topic belongs anywhere
Introducing myself and asking whether my planned first topic belongs anywhere Writing it up because I had to work it out twice and would rather nobody else did. I want to check my reasoning rather than get a…
CFHNDNLAID+13 18 4.2k 16mo
About the Pricing category
List prices, negotiated prices, and cost per milligram compared honestly across formats. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
JMBNHFDTMP+1 5 18k 15mo
Follow-up: External review after an internal denial
Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. A coverage question with the paperwork detail included, since that is what…
RVIWBENK+6 10 12k 15h
What happens when a maintainer goes quiet
The question in the title: What happens when a maintainer goes quiet I will give what I have already checked below so nobody repeats it. Nominating something for promotion into the documentation commons. The…
NOBAIHN+3 7 13k 2.1y
About the Repair & healing peptides category
BPC-157, TB-500 and similar. Mostly preclinical evidence; this subcategory is strict about not overstating it. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
SLHSENALEF 4 19k 13mo
When your prescriber and the evidence disagree
When your prescriber and the evidence disagree — that is the question, and I have not found it answered plainly anywhere I have looked. General question, not a request for advice about my own care — I know…
YERDKFKVKP+14 18 273 2d
Why retatrutide discussion here is more cautious than elsewhere
Why retatrutide discussion here is more cautious than elsewhere I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited…
DSCAKNKN+7 12 7.7k 2mo
Oral versus injectable exposure: comparing apples to a different fruit
Oral versus injectable exposure: comparing apples to a different fruit — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURMOUNT-4 ( JAMA ,…
JMMBCBJNNM+19 23 332 8mo
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold?
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to understand…
BDHFBWIBOF+14 18 3.4k 2mo
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA
Posting this under the heading it deserves: Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Everything below is what sits behind that. I have seen SCALE ( N Engl J Med , 2015) cited in support…
DVKAOARNGR+4 8 14k 8mo